MDXHEALTH (MDXH:NASDAQ)
$2.25 0.05 (2.2727%)
Analysed MDXHEALTH (MDXH:NASDAQ) News Sources
Liquid Biopsy Products Market Report 2026-2031 Featuring Analysis of Roche, Illumina, Qiagen, MDxHealth, Novogen, BGI, Myriad Genetics and More
20-03-2026
yahoo.com
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026
16-03-2026
yahoo.com
MDxHealth S.A. Q4 2025 Earnings Call Summary
27-02-2026
moby.co
MDxHealth SA (MDXH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Rising Losses
27-02-2026
yahoo.com
MDxHealth (MDXH) Q4 2025 Earnings Call Transcript
26-02-2026
fool.com
MDxHealth Q4 Earnings Call Highlights
26-02-2026
marketbeat.com
Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results
26-02-2026
yahoo.com
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26
12-02-2026
yahoo.com
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences
12-01-2026
yahoo.com
Loss-Making MDxHealth SA (NASDAQ:MDXH) Expected To Breakeven In The Medium-Term
08-01-2026
yahoo.com
What is the current price of MDXHEALTH (MDXH:NASDAQ)?
The current price of MDXHEALTH (MDXH:NASDAQ) is $2.25.
MDXHEALTH (MDXH:NASDAQ) absolute price change since previous trading day?
The absolute price change of MDXHEALTH (MDXH:NASDAQ) since the previous trading day is $0.05.
MDXHEALTH (MDXH:NASDAQ) percentage price change since previous trading day?
The percentage price change of MDXHEALTH (MDXH:NASDAQ) since the previous trading day is 2.2727%.
What is the most recent average sentiment score for MDXHEALTH (MDXH:NASDAQ)?
The most recent average sentiment score for MDXHEALTH (MDXH:NASDAQ) is 66 out of 100.
What is the most recent average sentiment for MDXHEALTH (MDXH:NASDAQ)?
The most recent sentiment for MDXHEALTH (MDXH:NASDAQ) is .
SEC-8K** Filing Available For MDXHEALTH (MDXH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.